These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12889224)

  • 1. Manual of signs, symptoms, methods and procedures for the assessment of the patient with SSc.
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S49-56. PubMed ID: 12889224
    [No Abstract]   [Full Text] [Related]  

  • 2. Conclusion and identification of the core set of variables to be used in clinical investigations.
    Valentini G; Medsger TA; Silman AJ; Bombardieri S
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S47-8. PubMed ID: 12889223
    [No Abstract]   [Full Text] [Related]  

  • 3. The assessment of the patient with systemic sclerosis. Introduction.
    Bombardieri S; Medsger TA; Silman AJ; Valentini G
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S2-4. PubMed ID: 12889213
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment of disease activity.
    Valentini G; Silman AJ; Veale D
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S39-41. PubMed ID: 12889221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of kidney involvement.
    Steen VD; Mayes MD; Merkel PA
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S29-31. PubMed ID: 12889219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of gastrointestinal involvement.
    Clements PJ; Becvar R; Drosos AA; Ghattas L; Gabrielli A
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S15-8. PubMed ID: 12889216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of vascular involvement.
    Kahaleh B; Meyer O; Scorza R
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S9-14. PubMed ID: 12889215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of heart involvement.
    Ferri C; Emdin M; Nielsen H; Bruhlmann P
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S24-8. PubMed ID: 12889218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic criteria, severity classification and guidelines of systemic sclerosis.
    Asano Y; Jinnin M; Kawaguchi Y; Kuwana M; Goto D; Sato S; Takehara K; Hatano M; Fujimoto M; Mugii N; Ihn H
    J Dermatol; 2018 Jun; 45(6):633-691. PubMed ID: 29687465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Best practices in scleroderma: an analysis of practice variability in SSc centres within the Canadian Scleroderma Research Group (CSRG).
    Harding S; Khimdas S; Bonner A; Baron M; Pope J;
    Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S38-43. PubMed ID: 22691207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis.
    Zulian F; Woo P; Athreya BH; Laxer RM; Medsger TA; Lehman TJ; Cerinic MM; Martini G; Ravelli A; Russo R; Cuttica R; de Oliveira SK; Denton CP; Cozzi F; Foeldvari I; Ruperto N
    Arthritis Rheum; 2007 Mar; 57(2):203-12. PubMed ID: 17330294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of disease severity and prognosis.
    Medsger TA; Bombardieri S; Czirjak L; Scorza R; Della Rossa A; Bencivelli W
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S42-6. PubMed ID: 12889222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of lung involvement.
    Matucci-Cerinic M; D'Angelo S; Denton CP; Vlachoyiannopoulos P; Silver R
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S19-23. PubMed ID: 12889217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non organ based laboratory markers in systemic sclerosis.
    McHugh NJ; Distler O; Giacomelli R; Riemekasten G
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S32-8. PubMed ID: 12889220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient preference disability questionnaire in systemic sclerosis: a cross-sectional survey.
    Mouthon L; Rannou F; Bérezné A; Pagnoux C; Guilpain P; Goldwasser F; Revel M; Guillevin L; Fermanian J; Poiraudeau S
    Arthritis Rheum; 2008 Jul; 59(7):968-73. PubMed ID: 18576298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison between general rheumatologists and scleroderma experts with respect to following systemic sclerosis guidelines.
    Reed J; Pope J
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S40-6. PubMed ID: 26121522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of scleroderma in a New Zealand tertiary rheumatology centre: emphasis on pulmonary complications.
    Ng K; Gow P
    N Z Med J; 2007 May; 120(1254):U2537. PubMed ID: 17515941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of skin, joint, tendon and muscle involvement.
    Akesson A; Fiori G; Krieg T; van den Hoogen FH; Seibold JR
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S5-8. PubMed ID: 12889214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group.
    Alhajeri H; Hudson M; Fritzler M; Pope J; Tatibouet S; Markland J; Robinson D; Jones N; Khalidi N; Docherty P; Kaminska E; Masetto A; Sutton E; Mathieu JP; Ligier S; Grodzicky T; LeClercq S; Thorne C; Gyger G; Smith D; Fortin PR; Larché M; Baron M
    Arthritis Care Res (Hoboken); 2015 Apr; 67(4):582-7. PubMed ID: 25233870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma lung disease, variation in screening, diagnosis and treatment practices between rheumatologists and respiratory physicians.
    Mangat P; Conron M; Gabbay E; Proudman SM;
    Intern Med J; 2010 Jul; 40(7):494-502. PubMed ID: 19460060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.